The IVS ITF, established in February 2002 under the IFPMA Biologicals and Vaccines Committee, represents 15 research-based vaccine manufacturers from around the world. IVS members produce most of the world’s influenza vaccines and conduct the R&D necessary to develop and produce safe, effective, high-quality human vaccines to protect against seasonal and pandemic influenza.

Meaning: 
Influenza Vaccine Supply International Task Force
Type of acronyms: 
Initiative
Category of acronyms: 
IFPMA
Alphabets: 
I